Salta al contenuto
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Avanzata
  • Current State of the Developme...
  • Citazione
  • Invia SMS
  • Invia email
  • Stampa
  • Esporta il record
    • Esporta a RefWorks
    • Esporta a EndNoteWeb
    • Esporta a EndNote
  • PLink permanente
Current State of the Development of Therapies for Emergency Prophylaxis and Treatment of Ebola Virus Disease

Current State of the Development of Therapies for Emergency Prophylaxis and Treatment of Ebola Virus Disease

Nowadays vaccination of the population living in the endemic regions and widespread implementation of the potent therapies for the emergency prophylaxis and treatment into the clinical practice are regarded as the basic efficient and cost-effective measures for Ebola epidemic spread control. Objecti...

Descrizione completa

Dettagli Bibliografici
Autori principali: A. A. Petrov, V. N. Lebedev, T. M. Plekhanova, L. F. Stovba, G. V. Borisevich, O. N. Sidorova, O. V. Chukhralya, S. V. Borisevich
Natura: Articolo
Lingua:Russian
Pubblicazione: Federal Government Health Institution, Russian Research Anti-Plague Institute “Microbe” 2015-09-01
Serie:Проблемы особо опасных инфекций
Soggetti:
вирус эбола
лекарственные средства
экстренная профилактика и лечение
вирусспецифические антитела
моноклональные антитела
малые интерферирующие рнк
антисмысловые фосфордиамидатные морфолиновые олигомеры
ebola virus
hemorrhagic fever
medical products
emergency prophylaxis and treatment
virus-specific antibodies
monoclonal antibodies
small interfering rna
anti-sense phosphordiamidate morpholine oligomers
Accesso online:https://journal.microbe.ru/jour/article/view/254
  • Posseduto
  • Descrizione
  • Documenti analoghi
  • MARC21

Accesso online

https://journal.microbe.ru/jour/article/view/254

Documenti analoghi

  • Monoclonal Antibodies and Recombinant Proteins for Immune-Diagnostics of Ebola Virus Disease
    di: E. I. Kazachinskaya, et al.
    Pubblicazione: (2015-09-01)
  • “CAMEL” ANTIBODIES: FEATURES OF THEIR STRUCTURE, PREPARATION AND APPLICATION
    di: Alexey Alekseevich Andreev, et al.
    Pubblicazione: (2020-06-01)
  • Analysis of Use of Antisense Oligonucleotides for Prevention and Treatment of Hazardous and Extremely Hazardous Viral Infectious Diseases
    di: A. A. Petrov, et al.
    Pubblicazione: (2020-05-01)
  • New Monoclonal Antibodies for the Diagnosis of Influenza and other Acute Respiratory Viral Infections
    di: A. A. Sominina, et al.
    Pubblicazione: (2015-10-01)
  • Systemic characteristic of safety profile of monoclonal antibodies used in rheumatology practice
    di: A. V. Philippova, et al.
    Pubblicazione: (2019-10-01)

Opzioni di ricerca

  • Ultime ricerche
  • Ricerca avanzata

Cerca

  • Scorri il catalogo
  • Scorri in ordine alfabetico
  • Esplora selezioni
  • Materiali riservati (per i corsi)
  • Nuovi documenti

Serve aiuto?

  • Suggerimenti per la ricerca
  • Chiedi al bibliotecario
  • FAQ